PMC:7796052 / 482-816 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7796052","sourcedb":"PMC","sourceid":"7796052","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7796052","text":"e of a drug repurposing campaign undertaken to identify bradykinin antagonists, raloxifene was identified as prospective compound in a virtual screening process. The pharmacodynamics profile of raloxifene towards bradykinin receptors is reported in the present work, showing a weak selective partial agonist profile at the B2 receptor","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"15","span":{"begin":56,"end":66},"obj":"Gene"},{"id":"16","span":{"begin":213,"end":223},"obj":"Gene"},{"id":"17","span":{"begin":323,"end":334},"obj":"Gene"},{"id":"19","span":{"begin":80,"end":90},"obj":"Chemical"},{"id":"20","span":{"begin":194,"end":204},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"Gene:3827"},{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"Gene:3827"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"Gene:624"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D020849"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:D020849"},{"subj":"15","pred":"source","obj":"LitCovid-PubTator"},{"subj":"16","pred":"source","obj":"LitCovid-PubTator"},{"subj":"17","pred":"source","obj":"LitCovid-PubTator"},{"subj":"19","pred":"source","obj":"LitCovid-PubTator"},{"subj":"20","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#93e5ec","default":true}]}]}}